Latest News in the pharma Industry

Top Stories

GSK announces significant new investment in UK manufacturing network

GSK announces significant new investment in UK manufacturing network

27 Jul 2016

Investment in advanced manufacturing of new respiratory and biopharmaceuticals portfolio.

Read more 
BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

27 Jun 2016

This milestone marks the sixth Breakthrough Therapy Designation for Opdivo.

Read more 
Shire completes combination with Baxalta

Shire completes combination with Baxalta

3 Jun 2016

Combined company expected to deliver double-digit compound annual top-line growth with over $20 billion in annual revenues by 2020.

Read more 
Valeant names Joseph C. Papa to be Chairman and CEO of Valeant Pharmaceuticals

Valeant names Joseph C. Papa to be Chairman and CEO of Valeant Pharmaceuticals

25 Apr 2016

Brings more than three decades of leadership and operations experience in healthcare.

Read more 
Pfizer–Allergan merger agreement terminated

Pfizer–Allergan merger agreement terminated

6 Apr 2016

Allergan reiterates strong standalone growth profile and strategy following termination of Pfizer transaction.

Read more 
Engineers develop a pill for long-term drug release

Engineers develop a pill for long-term drug release

6 Apr 2016

New tablet attaches to the lining of the GI tract, resists being pulled away.

Read more 
Sir Andrew Witty to retire from GSK in March 2017

Sir Andrew Witty to retire from GSK in March 2017

17 Mar 2016

The Board will now conduct a formal search for a successor and will consider internal and external candidates for the role.

Read more 
CMA fines pharma companies £45 million

CMA fines pharma companies £45 million

12 Feb 2016

The CMA has fined a number of pharmaceutical companies for anti-competitive conduct and agreements in relation to the supply of paroxetine.

Read more 
Shire to combine with Baxalta, creating the global leader in rare diseases

Shire to combine with Baxalta, creating the global leader in rare diseases

11 Jan 2016

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020.

Read more 
UBM celebrates securing more than 36000 attendees at biggest ever CPhI Worldwide

UBM celebrates securing more than 36000 attendees at biggest ever CPhI Worldwide

7 Jan 2016

World’s largest pharma event sees record exhibitor numbers in Madrid.

Read more 
Pfizer and Allergan to combine

Pfizer and Allergan to combine

23 Nov 2015

As a result of the combination with Allergan and subsequent integration of the two companies, Pfizer now expects to make a decision about a potential separation of the combined company's innovative and established businesses by no later than the end of...

Read more 
BMS to sell its HIV R&D portfolio to ViiV Healthcare

BMS to sell its HIV R&D portfolio to ViiV Healthcare

18 Dec 2015

Transactions are consistent with the evolution of BMS’s strategic focus, including the decision to discontinue its discovery efforts in virology announced in June.

Read more